ArticleThe Lancet. Oncology2020
The official French guidelines to protect patients with cancer against SARS-CoV-2 infection.
Article in The Lancet. Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04567979 (Prospective Determination of COVID-19 Infection Rate in Patients With Solid Tumors and Healthcare Workers of the Chemotherapy and Radiotherapy Unit at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador.), which is not on this map. Cited by 120 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prospective Determination of COVID-19 Infection Rate in Patients With Solid Tumors and Healthcare Workers of the Chemotherapy and Radiotherapy Unit at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador.
Who cites it
120 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain.The oncologist · 2020Guideline
- Hematological findings and complications of COVID-19.American journal of hematology · 2020Pooled it
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.Critical reviews in oncology/hematology · 2020Pooled it
- [COVID 19 and cancer: What are the consequences of the cancer care reorganization?]Bulletin du cancer · 2020Guideline
- Trial
- Nutritional and inflammatory biomarkers for COVID-19 susceptibility: a focus on vitamin D, potassium, and hematological indices.BMC infectious diseases · 2025Article
- Impact of COVID-19 pandemic on unresectable pancreatic cancer: a regional cohort study in Japan.Fukushima journal of medical science · 2025Article
- Article
- COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study.BMC cancer · 2025Observational
- Measuring reconceptualization and reprioritization during France's first COVID-19-related lockdown in women with and without a history of cancer: an adaptation of the SeiQol-DW and PGI.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- The Impact of the Pandemic on the Quality of Colorectal and Anal Cancer Care, and 2-Year Clinical Outcomes.Current oncology (Toronto, Ont.) · 2024Article
- Impact of treatment delays on future survival outcomes in non-surgical patients with esophageal cancer in Shandong Province, China.Frontiers in oncology · 2024Article
- Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.PloS one · 2024Article
- Article
- Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study.Journal of clinical medicine · 2023Article
- Cancer management during the COVID-19 world pandemic.Cancer immunology, immunotherapy : CII · 2023Review
- Article
- In-class transition (iCT) of proteasome inhibitor-based therapy: a community approach to multiple myeloma management.Blood cancer journal · 2023Article
- Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, France.Preventive medicine reports · 2023Article
- Impact of Disasters on Older Adult Cancer Outcomes: A Scoping Review.JCO global oncology · 2023Article
60 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Comment on
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.